The NLRP3 inflammasome activation promotes kidney injury process with up-regulation of IL-1β and IL-18 [13], [14] and enhances IL-1β levels in the type 2 diabetes [15]. This evidence concerns the gene IL1B and type 2 diabetes mellitus.